Log in to save to my catalogue

Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1992009950

Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

About this item

Full title

Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

Author / Creator

Publisher

New York: Springer US

Journal title

Clinical reviews in allergy & immunology, 2018-10, Vol.55 (2), p.205-216

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Eosinophilic esophagitis (EoE) is an immune-mediated, chronic esophageal disease characterized by esophageal symptoms and esophageal eosinophilia. It is triggered by foods and possibly by environmental allergens. Currently, there are no FDA-approved therapies for EoE. Commonly used treatments include dietary restrictions and topical corticosteroids...

Alternative Titles

Full title

Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1992009950

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1992009950

Other Identifiers

ISSN

1080-0549

E-ISSN

1559-0267

DOI

10.1007/s12016-018-8674-3

How to access this item